Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV002275564 | SCV002564169 | uncertain significance | DNAH14-Associated Neurodevelopmental Disorder | 2021-08-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004612171 | SCV005109702 | uncertain significance | not specified | 2024-06-04 | criteria provided, single submitter | clinical testing | The c.7733C>G (p.S2578C) alteration is located in exon 51 (coding exon 50) of the DNAH14 gene. This alteration results from a C to G substitution at nucleotide position 7733, causing the serine (S) at amino acid position 2578 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |